Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
- PMID: 8445992
- DOI: 10.1016/0024-3205(93)90194-8
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
Abstract
We determined the uptake blockade produced by eight new antidepressant drugs (etoperidone, femoxetine, lofepramine, nefazodone, paroxetine, sertraline, tomoxetine, and venlafaxine), two metabolites of newer antidepressants (desmethylsertraline and norfluoxetine), seven previously reported antidepressants, and carbamazepine. Inhibitor constants (Kis) for uptake blockade were obtained from competitive uptake studies with [3H]norepinephrine, [3H]5-hydroxytryptamine, and [3H]dopamine in rat brain synaptosomes prepared from hippocampus, frontal cortex, and striatum, respectively. Among the newer compounds, tomoxetine (Ki = 0.7 nM) and lofepramine (Ki = 1.9 nM) were potent and selective [3H]norepinephrine uptake blockers; paroxetine (Ki = 0.73 nM), sertraline (Ki = 3.4 nM), and femoxetine (Ki = 22 nM) potently and selectively inhibited [3H]5-hydroxytryptamine uptake. Although none of the drugs was potent for [3H]dopamine uptake blockade, sertraline was the most potent (Ki = 260 nM). These data are useful in predicting adverse effects and drug-drug interactions of antidepressants.
Similar articles
-
Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.Eur J Pharmacol. 1984 Sep 17;104(3-4):277-86. doi: 10.1016/0014-2999(84)90403-5. Eur J Pharmacol. 1984. PMID: 6499924
-
Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.Eur J Pharmacol. 1983 Nov 25;95(3-4):305-9. doi: 10.1016/0014-2999(83)90652-0. Eur J Pharmacol. 1983. PMID: 6653676
-
Preclinical evaluation of McN-5707 as a potential antidepressant.J Pharmacol Exp Ther. 1987 Jul;242(1):74-84. J Pharmacol Exp Ther. 1987. PMID: 3039115
-
Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.Postgrad Med J. 1976;52(3 suppl):33-9. Postgrad Med J. 1976. PMID: 785423 Review. No abstract available.
-
The interactions of tricyclic antidepressants with the biogenic amine uptake systems in the central nervous system.Postgrad Med J. 1976;52(3 suppl):25-32. Postgrad Med J. 1976. PMID: 785422 Review. No abstract available.
Cited by
-
Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.J Child Adolesc Psychopharmacol. 2015 Jun;25(5):432-9. doi: 10.1089/cap.2014.0167. J Child Adolesc Psychopharmacol. 2015. PMID: 26091197 Free PMC article. Clinical Trial.
-
Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.Clin Pharmacokinet. 1999 Aug;37(2):147-65. doi: 10.2165/00003088-199937020-00004. Clin Pharmacokinet. 1999. PMID: 10496302 Review.
-
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.Arch Gen Psychiatry. 2006 Oct;63(10):1121-9. doi: 10.1001/archpsyc.63.10.1121. Arch Gen Psychiatry. 2006. PMID: 17015814 Free PMC article. Clinical Trial.
-
Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.Br J Clin Pharmacol. 1999 Sep;48(3):345-54. doi: 10.1046/j.1365-2125.1999.00031.x. Br J Clin Pharmacol. 1999. PMID: 10510145 Free PMC article. Clinical Trial.
-
Effects of sertraline on autonomic and cognitive functions in healthy volunteers.Psychopharmacology (Berl). 2003 Jul;168(3):293-8. doi: 10.1007/s00213-003-1448-4. Epub 2003 Apr 12. Psychopharmacology (Berl). 2003. PMID: 12692706 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical